IMNN
Imunon, Inc.
Biotechnology · Healthcare · United States
0.91
close · 2026-10-30
value
1
cheaper than peers1
quality
5
stronger fundamentals5
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 2.19× | 53 |
| cash flow yield, latest year | -277.6% | 2 |
| cash flow yield, 1 year ago | -369.8% | 2 |
| earnings yield, latest year | -750.5% | 1 |
| cash flow yield, 2 years ago | -381.4% | 0 |
| cash flow yield, 3 years ago | -457.6% | 0 |
6 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 0.0% | 50 |
| return on equity | -429.7% | 6 |
| debt to equity | 187.3% | 3 |
3 of 4 measures available
Facts
| market cap | $5M |
| free cash flow | -$9.5M |
| employees | 20 |
| first trade | 1999-03-01 |
| next earnings | not reported |
| fundamentals updated | 2026-08-18 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -6.83 | -21.13 | -28.17 | -65.61 |
| free cash flow | -$14.2M | -$18.9M | -$19.5M | -$23.4M |
| net income | -$14.5M | -$18.6M | -$19.5M | -$35.9M |
| revenue | $0 | $0 | $0 | $500,000 |
| unusual items | $155,666 | $512,204 | $102,643 | -$8.0M |